Join to view full profile
5701 Eaglebend DrRichardson, TX 75082
Phone+1 972-437-4339
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Christopher Tehlirian, MD is a rheumatologist in Richardson, Texas. He is currently licensed to practice medicine in Massachusetts.
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 2005 - 2007- Johns Hopkins UniversityResidency, Internal Medicine, 2002 - 2005
McGovern Medical School at UTHealthClass of 2002
Certifications & Licensure
MA State Medical License 2013 - 2021
Publications & Presentations
PubMed
- 41 citationsOral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase...Christopher Tehlirian, Ravi Shankar P Singh, Vivek Pradhan, Erika S Roberts, Sanela Tarabar
Journal of the American Academy of Dermatology. 2022-08-01 - 25 citationsSafety and Pharmacokinetics of the Oral TYK2 Inhibitor PF-06826647: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation StudyRavi Shankar P. Singh, Vivek Pradhan, Erika S. Roberts, Matthew Scaramozza, Elizabeth Kieras
Clinical and Translational Science. 2021-03-01 - 19 citationsSafety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomi...Christopher Tehlirian, Elena Peeva, Elizabeth Kieras, Matthew Scaramozza, Erika S Roberts
The Lancet. Rheumatology. 2021-03-01
